U.S. FDA advisors recommend vaccine manufacturers target strains related to JN.1 variant.

Vaccine advisers to the FDA recommended changes to COVID vaccines Advisers to the Food and Drug Administration met Thursday to help decide which variant of the virus that causes COVID should be targeted by updated versions of the vaccines. NPR

...Moderna, Pfizer/BioNTech and Novavax should target strains related to the JN.1 variant with their vaccines for next fall and winter because that strain is closer to the new variants of the virus that are circulating, the advisers voted after a day-long meeting.

...

ALSO SEE: FDA vaccine advisers recommend sticking with JN.1 strain for next COVID vaccines